Ozempic and Similar Drugs Could Help Ward Off Dementia, Study Suggests

The case for Ozempic as a dementia buster is building. Research published this week has found that GLP-1 drugs are associated with a lower risk of dementia in people with type 2 diabetes. Researchers in Ireland led the study, a review of the existing evidence. Compared to controls (like other forms of medication or a placebo), people on GLP-1 therapy were significantly less likely to be diagnosed with dementia, the researchers found. Other scientists and pharmaceutical companies have already begun to test these drugs in clinical trials for dementia prevention. Ozempic, Wegovy, and similar drugs mimic the hormone GLP-1, which helps regulate our blood sugar and appetite (the drugs are made with the active ingredient semaglutide). These drugs were first approved to lower blood sugar in people with type 2 diabetes, but are now commonly also used to treat obesity. People with poorly controlled diabetes are at higher risk for Alzheimer’s and other forms of dementia, and recent clinical tr ... Read full article.